NGT BioPharma’s Sandy Farmer Ph.D. Tapped as Contributor to Congressional Report on Future of AI in Health Care

Approximately 20 to 25 participants representing pharma, biotech, academia, and government will come together in July to help define the future of AI in pharmaceutical R&D towards advancing health care in the United States. The specific focus will be to elucidate the opportunities and challenges for AI in drug discovery and development, with a broad view to the scientific, economic, ethical, legal and social aspects …